ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2140

Effects Of Intra-Articular Hyaluronic Acid Injections On Gait Pattern In Patients With Knee Osteoarthritis

Bilal Uysal1, Aysegul Ketenci2, Sina Esmaeilzadeh2 and Dilsad Sindel2, 1Physical Medicine And Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Physical Medicine and Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: hyaluronate, Knee, osteoarthritis and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects II: Symptoms and Therapeutics in Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: The aim of this study was to determine the effects of intra-articular hyaluronic acid (HA) injections on gait pattern of both injected and un-injected knees with motion analysis in patients with knee osteoarthritis (OA).

Methods: In a prospective study 49 eligible patients who had knee OA according to the American College of Rheumatology criteria and had grade II-III knee OA in the X-ray examination according to Kellgren and Lawrence Grading Scale, were included in the study. The HA was injected into the affected joints in 62 knees, once a week for three weeks. Gait analysis was performed at baseline, end of treatment protocol and 6-month after treatment by the ELITE Motion Analysis System (BTS S.p.a., Milan, Italy) and two force plates. The motion analysis was assessed by the Davis protocol. 

Results: The mean age of patients was 56.7 ± 6.3 (45-65) years; 45 (91.8%) were women. The ground reaction force was significantly decreased in the injected knees (p<0.05); however, there was no significant decrease (p>0.05) in the ground reaction force over six months. The extensor and flexor moments of the injected knees were significantly decreased (p<0.05) at the end of therapy and 6-month assessments compared with the un-injected knees (p>0.05). There were no significant changes in the walking velocity, stride time and stride length in both injected and un-injected knees over six months (p>0.05).

Conclusion: Our data suggest that intra-articular HA injections can reduce the ground reaction forces and flexion-extension moments, and consequently, lead to decrease in knee loading and improvement in the symptoms.


Disclosure:

B. Uysal,
None;

A. Ketenci,
None;

S. Esmaeilzadeh,
None;

D. Sindel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effects-of-intra-articular-hyaluronic-acid-injections-on-gait-pattern-in-patients-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology